Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 9—September 2006
Dispatch

Eighth Major Clade for Hepatitis Delta Virus

Frédéric Le Gal*1, Elyanne Gault*1, Marie-Pierre Ripault†, Jeanne Serpaggi‡, Jean-Claude Trinchet§, Emmanuel Gordien*, and Paul Dény*Comments to Author 
Author affiliations: *Hôpital Avicenne and EA3406, Université Paris 13, Bobigny, France; †Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, Paris, France; ‡Hôpital Necker, Assistance Publique - Hôpitaux de Paris, Paris, France; §Hôpital Jean Verdier, Assistance Publique - Hôpitaux de Paris, Bondy, France

Main Article

Figure 2

Maximum likelihood trees inferred from hepatitis delta virus (HDV) nucleotide sequences. Left panel: Maximum-likelihood phylogram obtained from the small hepatitis delta antigen dataset. Right panel: Maximum-likelihood phylogram obtained from the full-length HDV genome dataset. Bootstrap values (103 replicates) obtained for neighbor-joining and maximum parsimony are indicated above the branches; posterior probabilities (inferred from 5×103 trees generated from MrBayes application) are indicated

Figure 2. Maximum likelihood trees inferred from hepatitis delta virus (HDV) nucleotide sequences. Left panel: Maximum-likelihood phylogram obtained from the small hepatitis delta antigen dataset. Right panel: Maximum-likelihood phylogram obtained from the full-length HDV genome dataset. Bootstrap values (103 replicates) obtained for neighbor-joining and maximum parsimony are indicated above the branches; posterior probabilities (inferred from 5×103 trees generated from MrBayes application) are indicated below the branches. Asterisks indicate HDV sequences characterized in this study. Scale is in percent expected substitution per position. The accession numbers of the sequences used were AF209859, AF209859; Cagliari, X85253; China, X77627; dFr45, AX741164; dFr47, AX741149; dFr48, AX741164; dFr73, AX741154; dFr644, AX741169; dFr910, AX741159; dFr1843, AJ583885; dFr2005 (Guinea-Bissau), AM183331; dFr2020, AJ583887; dFr2072 (Senegal), AM183330; dFr2139 (Central African Republic), AM183332; dFr2158 (Cameroon), AM183333; dFr2600 (Togo), AM183326; dFr2627 (Nigeria), AM183329; dFr2703 (Senegal), AM183328; dFr2736 (Côte d'Ivoire), AM183327; Ethiopia, U81989; HDV-Iran, AY633627; Italy, X04451; Japan, X60193; L215, AB088679; Lebanon, M84917; Miyako, AF309420; Miyako-36, AB118845; Miyako-37, AB118846; Nagasaki-2, AB118849; Nauru, M58629; Peru-1, L22063; Somalia, U81988; Taiwan, M92448; Taiwan-3, U19598; Taiwan-Tw-2b, AF018077; Tokyo, AB118847; TW2476, AF104264; TW2667, AF104263; US-1, D01075; US-2, L22066; Vnzd8349, AB037948; Vnzd8375, AB037947; Vnzd8624, AB037949; Yakut-26, AJ309879; and Yakut-62, AJ309880.

Main Article

1These authors contributed equally to this work.

Page created: November 17, 2011
Page updated: November 17, 2011
Page reviewed: November 17, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external